Quantres Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-6,300
Closed -$237K 183
2017
Q4
$237K Sell
6,300
-6,900
-52% -$253K 0.15% 175
2017
Q3
$481K Buy
+13,200
New +$503K 0.31% 109
2016
Q3
Sell
-31,200
Closed -$1.04M 200
2016
Q2
$1.04M Buy
31,200
+22,200
+247% +$760K 0.65% 57
2016
Q1
$265K Buy
+9,000
New +$248K 0.25% 99
2015
Q1
Sell
-21,600
Closed -$459K 136
2014
Q4
$459K Buy
+21,600
New +$434K 0.45% 74

Other funds holding EW

Quantres Asset Management's EW Position: Q1 2018 in Review

Quantres Asset Management sold out of Edwards Lifesciences (EW) in Q1 2018, closing a stake of 6,300 shares — an estimated $237K sold.

Quantres Asset Management first reported a position in EW in Q4 2014 and held it in 5 quarters. The position peaked at $1.04M in Q2 2016. 815 funds tracked by Wall St. Rank hold EW as of Q1 2018.

  • Quantres Asset Management reported no remaining Edwards Lifesciences position as of Q1 2018 after selling out during the quarter.
  • Quantres Asset Management sold 6,300 Edwards Lifesciences shares in Q1 2018, an estimated $237K.
  • Quantres Asset Management first reported a position in Edwards Lifesciences in Q4 2014 and held it in 5 quarters.
  • Quantres Asset Management's Edwards Lifesciences position peaked at $1.04M in Q2 2016.
  • 815 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2018.

Based on Quantres Asset Management's 13F filing for Q1 2018, filed 3 May 2018.